Skip to main content

Advertisement

Log in

Application of central composite design for the optimization of itraconazole loaded nail lacquer formulation

  • Original Article
  • Published:
3 Biotech Aims and scope Submit manuscript

Abstract

Onychomycosis is a common fungal infection of the nails that mostly affects the elderly and athletes. Antifungal drug-like itraconazole is one of the therapeutic agents of choice for the topical treatment of onychomycosis. The current work aimed for the preparation and optimization of itraconazole-loaded nail lacquer formulation. Central composite design was employed; independent variables were polymer concentration (X1) and thioglycolic acid (TGA) concentration (X2). While the dependent variables were cumulative amount of drug permeated per unit area (CADP/A, Y1), drying time (Y2) and nonvolatile content (Y3). The optimized formulation was characterized for various parameters including ex-vivo permeation study, confocal laser scanning microscopy (CLSM) and antifungal study. The optimized nail lacquer formulation (F7) exhibited CADP/A of 198.23 µg/cm2, drying time of 185 s and nonvolatile content of 97.23%. The scanning electron microscopy of goat hoof treated with optimized nail lacquer formulation demonstrated loosening of the structure and marked increase in surface roughness. The CLSM micrograph of goat hoof treated with optimized nail lacquer formulation demonstrated that the probe dye was eventually distributed and penetrated through the hoof. Bio-adhesiveness analysis showed that the prepared nail lacquer film has ample adhesiveness to be maintained on the nail plate surface for a sufficient time. In antifungal study, the optimized nail lacquer, and marketed gel exhibited a zone inhibition of 21 mm, and 10 mm against Candida albicans, respectively. The stability study showed that the optimized nail lacquer is stable at storage condition. The prepared nail lacquers have been shown to serve as a useful dosage form for the delivery of itraconazole across nail plate for controlling the problems associated with onychomycosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

Availability of data and material

The authors confirm that the data findings of this study are available within the article.

References

  • Akhtar N, Sharma H, Pathak K (2016) Onychomycosis: potential of nail lacquers in transungual delivery of antifungals. Scientifica (cairo) 2016:1387936. https://doi.org/10.1155/2016/1387936

    Article  CAS  Google Scholar 

  • Ameeduzzafar QM, Alruwaili NK, Bukhari SNA, Alharbi KS, Imam SS, Afzal M, Alsuwayt B, Mujtaba A, Ali A (2021) BBD-based development of itraconazole loaded nanostructured lipid carrier for topical delivery: in vitro evaluation and antimicrobial assessment. J Pharm Innov 16:85–98

    Article  Google Scholar 

  • Bseiso EA, Nasr M, Sammour OA, Abd El Gawad NA (2016) Novel nail penetration enhancer containing vesicles “nPEVs” for treatment of onychomycosis. Drug Deliv 23:2813–2819

    Article  CAS  PubMed  Google Scholar 

  • Chouhan P, Saini TR (2012) Hydration of nail plate: a novel screening model for transungual drug permeation enhancers. Int J Pharm 436:179–182

    Article  CAS  PubMed  Google Scholar 

  • Christenson JK, Peterson GM, Naunton M, Bushell M, Kosari S, Baby KE, Thomas J (2018) Challenges and opportunities in the management of onychomycosis. J Fungi (basel). https://doi.org/10.3390/jof4030087

    Article  Google Scholar 

  • Cutrin-Gomez E, Anguiano-Igea S, Delgado-Charro MB, Gomez-Amoza JL, Otero-Espinar FJ (2018) Effect of penetration enhancers on drug nail permeability from cyclodextrin/poloxamer-soluble polypseudorotaxane-based nail lacquers. Pharmaceutics. https://doi.org/10.3390/pharmaceutics10040273

    Article  PubMed  PubMed Central  Google Scholar 

  • Del Rosso JQ (2014) The role of topical antifungal therapy for onychomycosis and the emergence of newer agents. J Clin Aesthet Dermatol 7:10–18

    PubMed  PubMed Central  Google Scholar 

  • Dhamoon RK, Popli H, Gupta M (2019) Novel drug delivery strategies for the treatment of onychomycosis. Pharm Nanotechnol 7:24–38

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Elewski BE (1998) Onychomycosis: pathogenesis, diagnosis, and management. Clin Microbiol Rev 11:415–429

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Faergemann J, Baran R (2003) Epidemiology, clinical presentation and diagnosis of onychomycosis. Br J Dermatol 149(Suppl 65):1–4

    Article  PubMed  Google Scholar 

  • Feng X, Xiong X, Ran Y (2017) Efficacy and tolerability of amorolfine 5% nail lacquer in combination with systemic antifungal agents for onychomycosis: A meta-analysis and systematic review. Dermatol Ther. https://doi.org/10.1111/dth.12457

    Article  PubMed  Google Scholar 

  • Ghannoum M, Isham N (2014) Fungal nail infections (onychomycosis): a never-ending story? PLoS Pathog 10:e1004105. https://doi.org/10.1371/journal.ppat.1004105

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ghannoum M, Long L, Kunze G, Sarkany M, Osman-Ponchet H (2019) A pilot, layerwise, ex vivo evaluation of the antifungal efficacy of amorolfine 5% nail lacquer vs other topical antifungal nail formulations in healthy toenails. Mycoses 62:494–501

    Article  CAS  PubMed  Google Scholar 

  • Gupta AK, Stec N (2019) Recent advances in therapies for onychomycosis and its management [version 1; peer review: 2 approved]. F1000Res 8(F1000 Faculty Rev):968. https://doi.org/10.12688/f1000research.18646.1

    Article  Google Scholar 

  • Hasan N, Singh M, Sulaiman S, Nandy S, Dudeja M, Ali A, Iqbal Z (2018) Design, development and optimization of a transungual duple nail lacquer for onychomycosis therapy. J Eur Acad Dermatol Venereol 32:e250–e251

    Article  CAS  PubMed  Google Scholar 

  • Hassan N, Singh M, Sulaiman S, Jain P, Sharma K, Nandy S, Dudeja M, Ali A, Iqbal Z (2019) Molecular docking-guided ungual drug-delivery design for amelioration of onychomycosis. ACS Omega 4:9583–9592

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hoda Q, Aqil M, Ahad A, Imam SS, Praveen A, Qadir A, Iqbal Z (2021) Optimization of valencene containing lipid vesicles for boosting the transungual delivery of itraconazole. Biotech 11:137. https://doi.org/10.1007/s13205-020-02497-7

    Article  Google Scholar 

  • Joshi M, Sharma V, Pathak K (2015) Matrix based system of isotretinoin as nail lacquer to enhance transungal delivery across human nail plate. Int J Pharm 478:268–277

    Article  CAS  PubMed  Google Scholar 

  • Kushwaha A, Jacob M, Shiva Kumar HN, Hiremath S, Aradhya S, Repka MA, Murthy SN (2015) Trans-ungual delivery of itraconazole hydrochloride by iontophoresis. Drug Dev Ind Pharm 41:1089–1094

    Article  CAS  PubMed  Google Scholar 

  • Lin H, Xie Q, Huang X, Ban J, Wang B, Wei X, Chen Y, Lu Z (2018) Increased skin permeation efficiency of imperatorin via charged ultradeformable lipid vesicles for transdermal delivery. Int J Nanomed 13:831–842

    Article  CAS  Google Scholar 

  • McAuley WJ, Jones SA, Traynor MJ, Guesne S, Murdan S, Brown MB (2016) An investigation of how fungal infection influences drug penetration through onychomycosis patient’s nail plates. Eur J Pharm Biopharm 102:178–184

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Monti D, Saccomani L, Chetoni P, Burgalassi S, Saettone MF, Mailland F (2005) In vitro transungual permeation of ciclopirox from a hydroxypropyl chitosan-based, water-soluble nail lacquer. Drug Dev Ind Pharm 31:11–17

    Article  CAS  PubMed  Google Scholar 

  • Monti D, Saccomani L, Chetoni P, Burgalassi S, Senesi S, Ghelardi E, Mailland F (2010) Hydrosoluble medicated nail lacquers: in vitro drug permeation and corresponding antimycotic activity. Br J Dermatol 162:311–317

    Article  CAS  PubMed  Google Scholar 

  • Murdan S (2002) Drug delivery to the nail following topical application. Int J Pharm 236:1–26

    Article  CAS  PubMed  Google Scholar 

  • Nair AB, Kim HD, Chakraborty B, Singh J, Zaman M, Gupta A, Friden PM, Murthy SN (2009) Ungual and trans-ungual iontophoretic delivery of terbinafine for the treatment of onychomycosis. J Pharm Sci 98:4130–4140

    Article  CAS  PubMed  Google Scholar 

  • Nesseem DI (2001) Formulation and evaluation of itraconazole via liquid crystal for topical delivery system. J Pharm Biomed Anal 26:387–399

    Article  CAS  PubMed  Google Scholar 

  • Piraccini BM, Iorizzo M, Lencastre A, Nenoff P, Rigopoulos D (2020) Ciclopirox hydroxypropyl chitosan (HPCH) nail lacquer: a review of its use in onychomycosis. Dermatol Ther (heidelb) 10:917–929

    Article  Google Scholar 

  • Saner MV, Kulkarni AD, Pardeshi CV (2014) Insights into drug delivery across the nail plate barrier. J Drug Target 22:769–789

    Article  CAS  PubMed  Google Scholar 

  • Shah VH, Jobanputra A (2018) Enhanced ungual permeation of terbinafine HCl delivered through liposome-loaded nail lacquer formulation optimized by QbD approach. AAPS PharmSciTech 19:213–224

    Article  CAS  PubMed  Google Scholar 

  • Shirwaikar AA, Thomas T, Shirwaikar A, Lobo R, Prabhu KS (2008) Treatment of onychomycosis: an update. Indian J Pharm Sci 70:710–714

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Shivakumar HN, Vaka SR, Madhav NV, Chandra H, Murthy SN (2010) Bilayered nail lacquer of terbinafine hydrochloride for treatment of onychomycosis. J Pharm Sci 99:4267–4276

    Article  CAS  PubMed  Google Scholar 

  • Shivakumar HN, Juluri A, Desai BG, Murthy SN (2012) Ungual and transungual drug delivery. Drug Dev Ind Pharm 38:901–911

    Article  CAS  PubMed  Google Scholar 

  • Tanriverdi ST, Hilmioglu Polat S, Yesim Metin D, Kandiloglu G, Ozer O (2016) Terbinafine hydrochloride loaded liposome film formulation for treatment of onychomycosis: in vitro and in vivo evaluation. J Liposome Res 26:163–173

    Article  PubMed  Google Scholar 

  • Thapa RK, Choi JY, Go TG, Kang MH, Han SD, Jun JH, Son MW, Yong CS, Kim JO (2016) Development of ciclopirox nail lacquer with enhanced permeation and retention. Arch Pharm Res 39:953–959

    Article  CAS  PubMed  Google Scholar 

  • Thatai P, Sapra B (2018) Terbinafine hydrochloride nail lacquer for the management of onychomycosis: formulation, characterization and in vitro evaluation. Ther Deliv 9:99–119

    Article  CAS  PubMed  Google Scholar 

  • Vanden Bossche H, Marichal P, Le Jeune L, Coene MC, Gorrens J, Cools W (1993) Effects of itraconazole on cytochrome P-450-dependent sterol 14 alpha-demethylation and reduction of 3-ketosteroids in Cryptococcus neoformans. Antimicrob Agents Chemother 37:2101–2105

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Vipin KV, Sarath CC, Ann RA, Premaletha K, Kuriakose MR (2014) Formulation and evaluation of an antifungual nail lacquer for onychomycosis. Br Biomed Bull 2:242–248

    CAS  Google Scholar 

  • Zeb A, Qureshi OS, Kim HS, Cha JH, Kim JK (2016) Improved skin permeation of methotrexate via nanosized ultradeformable liposomes. Int J Nanomedicine 11:3813–3824

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Funding

None.

Author information

Authors and Affiliations

Authors

Contributions

AR: Investigation, formulation, methodology. MA: Ideas, supervision, conceptualization. AA: Software, writing original draft preparation. SSI: Software, interpreting the data. AQ: Data collection. AALI: Ideas, design of methodology.

Corresponding authors

Correspondence to Mohd. Aqil, Abdul Ahad or Asgar Ali.

Ethics declarations

Conflicts of interest

The authors report no declarations of interest.

Ethics approval and consent to participate

None.

Consent for publication

Not applicable.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rahman, A., Aqil, M., Ahad, A. et al. Application of central composite design for the optimization of itraconazole loaded nail lacquer formulation. 3 Biotech 11, 324 (2021). https://doi.org/10.1007/s13205-021-02862-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s13205-021-02862-0

Keywords

Navigation